Join Norman Mains as he discusses:
What are the advantages of liquid alternatives?
How does the historical performance of liquid alts compare?
How do liquid alts fit into investor portfolios?
For decades our data center owners and operators have feinted at the thought of water and liquids in the data center. But, it is already happening in many data centers and has been for some time in some facilities. What are the different technologies available to data centers today? Where can they best be used? Which ones are best suited for which environments? When can we expect to see them in our data centers? Bruce will discuss the “ins and outs” of liquid cooled technologies yesterday, today and tomorrow. Get ready for some surprises in the process.Read more >
Geminal dicationic and polyionic ionic liquids have been prepared for use as stationary phases in capillary gas chromatography. These materials are known to provide higher thermal stability for gas chromatography, broader liquid working ranges and broader selectivity ranges than monocationic ionic liquids and polymeric based stationary phases with similar polarity. Recently, a new ionic liquid stationary phase has been developed that provides a selectivity very similar to a polyethylene glycol (PEG) selectivity but with increased thermal stability and lower bleed. We will compare and contrast the similar but unique selectivity of this new phase with traditional PEG phases using a wide variety of different sample types. We will demonstrate the improved thermal stability and lower bleed through a series of different studies and applications.Read more >
Webcast on ETSI Mobile Edge Computing Proof of Concept #2: on Edge Video Orchestration and Incident Reporting.
Delivered by Dirk Lindemeier, Head of Liquid Applications at Nokia, Matt Stagg, Network Strategy with EE and Klaus Magora, CTO of Smart Mobile Labs, this webinar describes the use of ETSI's MEC standards to deliver Edge Video Orchestration and Incident Reporting use cases at Wembley Stadium, UK.
The fatty acid composition of a fat or oil is most commonly assessed by gas chromatography, following conversion of the fatty acids methyl esters. The current most refined analytical methods for the quantitation of trans fatty acids rely on the separations provided by long cyanopropyl siloxane capillary columns. The introduction of capillary columns coated with ionic liquids, such as Supelco SLB-IL111, provide an alternative separation tool characterized by a higher stationary phase polarity and selectivity toward geometric and positional isomers of unsaturated fatty acids. The use of these novel capillary columns can provide more refined separations of complex lipid samples. As a result, most conjugated linoleic acid isomers (including t7,c9- and c9,t11-18:1 FA) can be quantitated in a single separation using a 100 m SLB-IL111 capillary column and most 18:1 FA positional and geometric isomers can be separated using a 200 m SLB-IL111. Ionic liquid columns provide more detailed FA profiles, especially for unsaturated fatty acid positional/geometric isomers.Read more >
Data center energy efficiency is being attacked from numerous directions, including power distribution innovations, the creation of hardware better suited to customer applications (to drive better IT utilization), co-designing data centers with IT solutions, and cooling system innovations.
With respect to cooling systems, the widely-recognized Power Usage Effectiveness (PUE) from The Green Grid (TGG), which is a direct measure of data center energy efficiency, has been used to great effect to continuously drive down “traditional” air-cooled data center PUEs. In the high performance computing (HPC) space, where 40 kW+ rack power densities are commonplace, more aggressive cooling technologies such as liquid-cooling, are seeing rapid adoption. There is also increasing evidence that liquid-cooling is making its way into non-HPC data centers. The presentation will cover such topics as:
· Data center energy efficiency trends
· An overview of liquid-cooling technologies
· The role that liquid-cooled IT is playing in driving improved energy efficiency – towards a PUE of 1.1
· The challenges of implementing liquid-cooling in the IT and data centers
The goal is to help demystify liquid-cooling. Finally, The Green Grid’s recently announced Liquid-Cooling Work Group will be described.
What are the considerations and implications when holding liquid and illiquid assets in a portfolio.Read more >
This webinar will consist of 2 parts:
1. Answers to your questions asked in Professor Schoenmakers' Introduction to Liquid Chromatography webinar.
2. An interactive Q&A session for Dr Polite's "Resolution in Liquid Chromatography" video tutorial.
Chromedia, for a limited time only, will provide Dr Lee Polite's video tutorial Resolution in LC available completely for free!
Liquid Robotics - Frost & SullivanRead more >
Ionic liquids (ILs) and their components have had a substantial impact on the capabilities and performance of gas chromatography, ESI-MS and MALDI-MS. For GC this ranges from the analysis of complex mixtures by GC x GC, water quantitation and food/beverage analysis among other areas. In MS the most sensitive analysis of anions, phospholipids and metal cations is often done by ESI-MS using complex IL cationic reagents. Also the best MALDI matrices for many proteins, peptides, carbohydrates and synthetic polymers are based on ILs. These will be discussed as time permits.Read more >
BNYM AI Multi-Strategy (40Act) Q4 updateRead more >
In this webinar, Professor Peter Schoenmakers will provide insight into the various LC techniques, including:
* An overall perspective of current usage and applications of the various techniques.
* A description of how the techniques developed, starting from paper chromatography up-to current "high tech" two-dimensional separations.
* A more detailed focus on the concept of various methods.
Often portrayed more as magic than science, popular television series such as CSI have aroused great interest in analytical chemistry. Forensic science relies on separation science.
Peter Schoenmakers' webinar will also, in a light-hearted manner, put LC methods into the correct perspective for forensic science.
In this 1-hour webcast, Cray customer Mississippi State University will share best practices in maximizing datacenter energy efficiency and explain why they chose the Cray® CS300-LC™ cluster solution based on Intel® Xeon® processors and Xeon Phi™ coprocessors. Topics will include architecture and facility considerations such as site selection, risk factors and issues impacting TCO. Attendees will learn about key benefits of the CS300-LC’s innovative design—which uses warm water heat exchangers instead of chillers to efficiently cool the system and maximize performance—as well as remote monitoring and cooling system management.
A Q&A session will be held following speaker presentations. Sign up today and join the conversation!
Join the webcast to learn about:
1. Key factors to consider when choosing a cluster architecture with liquid cooling
2. Achieving significant power savings, reliability and performance scalability with managed cooling control.
3. Optimizing power efficiency and system performance using Intel® Xeon® processors and Xeon Phi™ coprocessors
Cray is a global supercomputing leader with a comprehensive portfolio of compute, storage and Big Data analytics solutions. Cray’s expertise enables fast application results and real-time discovery in technical and scientific computing.
About Mississippi State University
The High Performance Computing Collaboratory at Mississippi State University is a coalition dedicated to advancing computational science and engineering using high performance computing. Mississippi State consistently ranks among the nation's fastest academic computing sites on the TOP500 list.
CDS indices offer a full and liquid exposure to the high yield market. They have been outperforming high yield cash bonds since 2004.Read more >
• The current positioning of the UK Property Fund.
• The Fund’s allocation to liquid assets.
• Fair Value Pricing and why it is necessary.
• Some recent examples of on-going asset management initiatives within the portfolio.
New vaccine process designs – and all the kinks that go with them – are typically hammered out in a small scale capacity, for example, prior to manufacturing for early phase human clinical trials. They are then upsized and further defined for industrial scale to supply the vast market. Single-use technologies (SUTs) have been a hot topic for several years now and their advantages well-known: easy product changeover, processing in lower classification areas, reduced CAPEX, elimination of glass, sterility assurance, to name a few. In vaccine manufacturing, SUTs are used throughout the processing stages, from cell culture all the way to filling. SUTs are quickly and conveniently designed, purchased and implemented for short-term manufacturing of clinical trial phase materials. Here a large percentage of new vaccines in Research and Development do not even make it to market.
As the final production stages are critical as they are the last stages before patient injection, the scope of thisarticle covers SU applications involving drug substance formulations, adjuvant processing, final bulk formulation and filling. The actual process itself may include some or all of the following: filtration, pumping, ingredient addition, mixing, adsorption, filling, labelling, sampling and and storage.
In this presentation only liquid formulations (“presentations”) will be discussed.
Jerome Berset, Senior Portfolio Manager, explains the benefits of adding this liquid alternatives fund of hedge fund to an investment portfolioRead more >
For the past two decades, Solid Phase Microextraction (SPME) has represented a convenient alternative to conventional sample prep procedures. SPME allows the simultaneous extraction and enrichment of analytes of interest from a given matrix in a single step while avoiding, or drastically minimizing, the use of organic solvents and time-consuming cleanup procedures.
Like any other analytical method, the various parameters governing the SPME process need to be carefully optimized in order to achieve robustness and sensitivity. However, certain aspects of SPME method development are often overlooked by many users, leading to unsatisfactory performance of the technique.
This webinar will shed light into several aspects of SPME method development. The presentation will include a theoretical explanation of SPME fundamentals and practical suggestions to overcome common errors and bias encountered when using SPME.
The webinar is divided in three main sections: 1) optimization of extraction conditions 2) matrix modifications 3) optimization of desorption conditions for gas and liquid chromatography. Each section is divided in various subsections dedicated to each parameter affecting the performance of the SPME technique. The webinar attendees will be guided through comprehensive understanding of the technology and the critical parameters that influence the extraction process with practical examples from already existing methods.
Paris is the largest, most liquid, and most transparent investment market for real estate investors in Europe. Thomas Guyot, Head of Real Estate Investment France, walks through a 23,000sqm asset located in Paris Rive Gauche. The JV was structured when the project was largely de-risked, and is the best performing asset in the portfolio today.Read more >
Cell culture media is required for successful and reproducible research but the catalog is full of acronyms and various formulation tables. Classical mammalian cell culture media formulations are very diverse both in terms of the number available and the concentration of constituents. Additionally, each medium was designed for specific cell types and culturing conditions.
This webinar will cover:
•The composition, characteristics, environmental factors, and additional supplements required to create optimal conditions for growth and productivity.
•Determining the right formulation for your application.
•Serum usage and helpful tips for optimizing your culture conditions.
Brian Posey is a Product Development Manager for cell culture media at Corning Life Sciences. Brian has over 10 years experience in cell biology and industrial scale cGMP manufacturing of both liquid and powder cell culture media. Since joining Corning in 2012, Brian has led numerous innovative technology projects for the media business ranging from customer technology transfer for production scale-up to developing new serum-free media for industrial and stem cell lines.
The global pharmaceutical industry is witnessing an unprecedented era. Several new demand spaces such as innovative therapeutics (immuno-oncology), clinical diagnostics (liquid biopsy), and research tools (next-generation sequencing) have emerged, driving companies to sharpen their long-term positions. Fundamental behavioral shifts in these spaces are redefining the market. Companies are adopting a “beyond-the-pill” approach and increasing investments in innovations related to drug discovery, clinical trials, supply-chain solutions, and patient engagement. This briefing reviews recent industry transformations, changes in business models, growth opportunities, and key predictions for the life sciences industry.Read more >
Volatile capital markets and the rapidly changing financial landscape make it important for issuers to recognise changes quickly and adjust their financing strategies accordingly.
For example, for an issuer that contemplated an IPO or is in the IPO queue, it is important to become familiar with other financing alternatives, such as venture debt or late-stage or mezzanine debt, as well as institutional equity private placements. Each of these markets is quite different. Familiarity with investor expectations and documentation requirements is essential in order to put your company in the best position to make crisp decisions. For issuers that already have their securities listed on a non-US securities exchange, which may offer limited liquidity, it may be time to consider undertaking a US IPO in order to establish a more liquid market for their securities. Already public companies considering their next capital raise also must be nimble - a PIPE transaction may be an attractive (and available) financing alternative. During this session, the speakers will discuss:
•Current market conditions;
•Financing alternatives for pre-IPO companies;
•The market for venture debt;
•The late-stage (or cross-over) private placement market;
•Options to consider on the way to an IPO;
•Financing alternatives for recently public companies; and
•PIPE transactions and other financing alternatives.
The webinar's speakers will be:
-Geoffrey Goodman, managing director, equity capital markets, Wells Fargo
-Gregory Ogborn, director, equity capital markets, Wells Fargo
-Brian Maier, vice chairman, Wells Fargo
-Anna Pinedo, partner, Morrison & Foerster
-James Tanenbaum, partner, Morrison & Foerster